Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews
The DOI matches its Crossref record, with a small difference in title or year; 28 of the 28 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Irritable bowel syndrome (IBS) is a common disorder of the gastrointestinal tract, about which there has been considerable recent research. The aim of this article is to briefly review the aspects of IBS pathogenesis that involve the gastrointestinal microbiota, and then to critically appraise the recent and emerging evidence for the use of probiotics and prebiotics in its management. RECENT FINDINGS: The increased risk of developing IBS following gastroenteritis and the co-existence of dysbiosis, elevated luminal gas production and immune activation, indicate that the gastrointestinal microbiota may be a therapeutic target in IBS. Most systematic reviews indicate that probiotics have a beneficial impact on global IBS symptoms, abdominal pain and flatulence. However, recent trials indicate that different probiotics can improve, have no effect, or even worsen symptoms, confirming that benefits are likely to be strain and symptom-specific. There are no recent clinical trials of prebiotics in IBS, although previous studies indicate potential benefit at lower doses. SUMMARY: Clearly, some probiotics have considerable potential in the management of IBS; however, the benefits are likely to be strain-specific. Preliminary studies suggest low doses of prebiotics may improve symptoms of IBS, although further robust clinical trials are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effectiveness of probiotics in improving IBS symptoms has been tentatively recognized, and several probiotic strains have been demonstrated to benefit patients with IBS [25,26,27].”
In the citing paper
“Given that changes in the gut microbiota have been implicated in the pathogenesis of GI disorders [such as irritable bowel syndrome (IBS)],5–8 there is growing interest in therapies that might influence these changes, such as probiotics.”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [8]
In the citing paper
“An overview of meta-analyses in IBS showed a similar trend, with more supportive evidence available for overall symptom burden and abdominal pain than for flatus.8”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [8]
In the citing paper
“The Consensus Group concluded, with a high level of evidence, that specific probiotics help reduce overall symptom burden and abdominal pain in IBS (Statements 1 and 4: 100% agreement among voters), consistent with previous meta-analyses and reviews.2,8”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [8]
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Prebiotic effects: metabolic and health benefits
Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,085
Self-citationSonnenburg, E. D., Zheng, H., Joglekar, P., Higginbottom, S. K., Firbank, S. J., Bolam, D. N., & Sonnenburg, J. L. (2010) · Cell · doi:10.1016/j.cell.2010.05.005 · Cited by 748
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617
Ong, D. K., Mitchell, S. B., Barrett, J. S., Shepherd, S. J., Irving, P. M., Biesiekierski, J. R., Smith, S., Gibson, P. R., & Muir, J. G. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06370.x · Cited by 583
SILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551
Staudacher, H. M., Whelan, K., Irving, P. M., & Lomer, M. C. E. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2011.01162.x · Cited by 436
Self-citationMarshall, J. K., Thabane, M., Garg, A. X., Clark, W. F., Salvadori, M., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.053 · Cited by 375
Research works printed but not linked: 3
- Spiller, 2010, epatol, 8, 125
- Pimentel, 364, N Engl J Med, 22-, 32
- Huertas-Ceballos, 2009, Cochrane Database Syst Rev, 1, CD003019
Cited by
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“Possibly, the loss of particular TJ proteins such as occludin is a result of increased proteasome-mediated degradation observed in IBS triggered by low-grade inflammation and resulting in increased intestinal permeability [196].”
ResultInfluentialStaudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.159285 · Cited by 590
“Finally, a number of studies have indicated the potential therapeutic benefit of bifidobacteria probiotics in IBS (42).”
BackgroundSelf-citationKonturek, P. C., Brzozowski, T., & Konturek, S. J. (2011) · PubMed · Cited by 818
Can probiotics modulate human disease by impacting intestinal barrier function?
Bron, P. A., Kleerebezem, M., Brummer, R.-J., Cani, P. D., Mercenier, A., MacDonald, T. T., Garcia-Ródenas, C. L., & Wells, J. M. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114516004037 · Cited by 499
Brain gut microbiome interactions and functional bowel disorders
Mayer, E. A., Savidge, T., & Shulman, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.037 · Cited by 496
Song, H., Yoo, Y., Hwang, J., Na, Y.-C., & Kim, H. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.021 · Cited by 416
Didari, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3072 · Cited by 356
A role for the gut microbiota in IBS
Collins, S. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.40 · Cited by 351
Rastall, R. A., & Gibson, G. R. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.11.002 · Cited by 298
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“418,419 Although research on the pathophysiological mechanisms of DN covers multiple aspects, several pathways remain poorly understood, and the clinical application of treatment strategies remains limited.”
Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders in Adults
Guarino, M., Altomare, A., Emerenziani, S., Di Rosa, C., Ribolsi, M., Balestrieri, P., Iovino, P., Rocchi, G., & Cicala, M. (2020) · Nutrients · doi:10.3390/nu12041037 · Cited by 274
Mechanisms and efficacy of dietary FODMAP restriction in IBS
Staudacher, H. M., Irving, P. M., Lomer, M. C. E., & Whelan, K. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.259 · Cited by 242
Self-citationHungin, A. P. S., Mulligan, C., Pot, B., Whorwell, P., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J.-M., Rubin, G., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12460 · Cited by 212
“meta-analyses in IBS showed a similar trend, with more supportive evidence available for overall symptom burden and abdominal pain than for flatus.(8) Nevertheless, a meta-analysis of studies in adults with IBS did report a significant reduction in flatus with probiotic treatment.”
Immunological properties of inulin-type fructans
Vogt, L., Meyer, D., Pullens, G., Faas, M., Smelt, M., Venema, K., Ramasamy, U., Schols, H. A., & De Vos, P. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.656772 · Cited by 195
“TNF-α, and IL-1a mRNA levels in mucosal tissue were significantly reduced (p = 0.0175 and p = 0.0379) but also, a significant increase in IL-10 positive CD11+ DCs and expression of TLR2 and TLR4 was reported (Macfarlane et al., 2005).”
BackgroundInfluentialProbiotics in the management of irritable bowel syndrome and inflammatory bowel disease
Whelan, K., & Quigley, E. M. M. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835d7bba · Cited by 183
“Furthermore, at least six systematic reviews (five of which included meta-analysis) have been published on probiotics in IBS.([20]) The six systematic reviews included RCTs in children only,([21]) adults only and children or adults.”
BackgroundInfluentialSelf-citationDuPont, H. L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12728 · Cited by 171
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160
“According to these results, prebiotic treatment may be considered a double-edged sword for patients with IBS, as high dosages of prebiotics can exacerbate symptoms rather than improve them, through their fermentation by microbiota and the consequent increase in the quantity of gas in the large bowel (Whelan, 2011).”
BackgroundCan probiotics benefit children with autism spectrum disorders?
Navarro, F., Liu, Y., & Rhoads, J. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i46.10093 · Cited by 154
A dietary survey of patients with irritable bowel syndrome
Hayes, P., Corish, C., O'Mahony, E., & Quigley, E. M. M. (2014) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12114 · Cited by 140
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Li, M., Wang, M., & Donovan, S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0033-1361825 · Cited by 131
How to Manipulate the Microbiota: Prebiotics
Louis, P., Flint, H. J., & Michel, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_9 · Cited by 154
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate
Gallo, A., Passaro, G., Gasbarrini, A., Landolfi, R., & Montalto, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7186 · Cited by 119
Aziz, M., Kumar, J., Nawawi, K. N. M., Ali, R. A. R., & Mokhtar, N. M. (2021) · Nutrients · doi:10.3390/nu13093061 · Cited by 128
Probiotics and prebiotics: prospects for public health and nutritional recommendations
Sanders, M. E., Lenoir‐Wijnkoop, I., Salminen, S., Merenstein, D. J., Gibson, G. R., Petschow, B. W., Nieuwdorp, M., Tancredi, D. J., Cifelli, C. J., Jacques, P., et al. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12377 · Cited by 100
Wang, H., Gong, J., Wang, W., Long, Y., Fu, X., Fu, Y., Qian, W., & Hou, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090153 · Cited by 103
“individual symptoms of IBS patients[11,12,13,14,15,16].”
Inflammation in irritable bowel syndrome: Myth or new treatment target?
Sinagra, E., Pompei, G., Tomasello, G., Cappello, F., Morreale, G. C., Amvrosiadis, G., Rossi, F., Monte, A. I. L., Rizzo, A. G., & Raimondo, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2242 · Cited by 120
“Finally, probiotics have also been found to be effective in select IBS patients, as suggested by several recent systematic reviews, guidelines and meta-analyses, by improving intestinal permeability [208-212] .”
Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health
Ceapa, C., Wopereis, H., Rezaïki, L., Kleerebezem, M., Knol, J., & Oozeer, R. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.04.004 · Cited by 98
Castori, M., Morlino, S., Pascolini, G., Blundo, C., & Grammatico, P. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31431 · Cited by 98
Spiller, R., Pélerin, F., Cayzeele Decherf, A., Maudet, C., Housez, B., Cazaubiel, M., & Jüsten, P. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640615602571 · Cited by 87
“The ITT population was defined as all subjects who were randomized (N¼ 379, active group N¼ 192, placebo group N¼ 187) whereas PP population included subjects of the ITT population presenting no major protocol deviations, and where IBS-C: constipation predominant IBS; IBS-D: diarrhea predominant IBS; IBS-M: mixed IBS.…”
BackgroundInfluentialSteinert, R. E., Sadabad, M. S., Harmsen, H. J. M., & Weber, P. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.119 · Cited by 84
Tait, C., & Sayuk, G. S. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.12.023 · Cited by 85
Using Probiotics in Gastrointestinal Disorders
Ringel, Y., Quigley, E. M., & Lin, H. C. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.7 · Cited by 77
Yang, B. K., Yue, Y., Chen, Y., Ding, M., Li, B., Wang, L., Wang, Q., Stanton, C., Ross, R. P., Zhao, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746585 · Cited by 90
Mazurak, N., Broelz, E., Storr, M., & Enck, P. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15071 · Cited by 71
Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study
Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001478 · Cited by 71
Rogha, M., Esfahani, M. Z., & Zargarzadeh, A. H. (2014) · Gastroenterology and hepatology from bed to bench. · Cited by 91
Sudha, M. R., Jayanthi, N., Aasin, M., Dhanashri, R. D., & Anirudh, T. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0129 · Cited by 72
The Human Microbiome and Public Health: Social and Ethical Considerations
O’Doherty, K. C., Virani, A., & Wilcox, E. (2016) · American Journal of Public Health · doi:10.2105/ajph.2015.302989 · Cited by 69
The Role of the Gastrointestinal Microbiota in Visceral Pain
Rea, K., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_115 · Cited by 69
Jalanka, J., Salonen, A., Fuentes, S., & de Vos, W. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1096486 · Cited by 61
Whelan, K. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001262 · Cited by 70
Self-citationXu, H., Ma, C., Zhao, F., Chen, P., Liu, Y., Sun, Z., Cui, L., Kwok, L. Y., & Zhang, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02437-4 · Cited by 64
Prebiotics, probiotics and digestive health
Balakrishnan, M., & Floch, M. H. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328359684f · Cited by 53
“It is a challenging clinical problem for the patients, as well as the treating physician [22].”
BackgroundLudidi, S., Jonkers, D. M., Koning, C. J., Kruimel, J. W., Mulder, L., van der Vaart, I. B., Conchillo, J. M., & Masclee, A. A. M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12320 · Cited by 49
Irritable Bowel Syndrome: Modern Concepts and Management Options
Sayuk, G. S., & Gyawali, C. P. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.01.036 · Cited by 62
“Emerging data similarly support probiotics, especially Bifidobacteria, Lactobacillus, and Saccharomyces species.(110,111) Although all probiotics likely are not equal in effectiveness, head-to-head comparisons are lacking.”
ResultIrritable Bowel Syndrome: Contemporary Nutrition Management Strategies
Mullin, G. E., Shepherd, S. J., Roland, B. C., Ireton-Jones, C. S., & Matarese, L. E. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114545329 · Cited by 54
Horvath, A., Dziechciarz, P., & Szajewska, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i20.3062 · Cited by 53
Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome
Thijssen, A. Y., Clemens, C. H. M., Vankerckhoven, V., Goossens, H., Jonkers, D. M. A. E., & Masclee, A. A. M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000484 · Cited by 45
Lohner, S., Küllenberg, D., Antes, G., Decsi, T., & Meerpohl, J. J. (2014) · Nutrition Reviews · doi:10.1111/nure.12117 · Cited by 43
The gut microbiome and irritable bowel syndrome: State of art review
Salem, A., Singh, R., Ayoub, Y. K., Khairy, A. M., & Mullin, G. E. (2018) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2018.02.008 · Cited by 50
Effects of the Modulation of Microbiota on the Gastrointestinal Immune System and Bowel Function
Kanauchi, O., Andoh, A., & Mitsuyama, K. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf402441f · Cited by 43
Cheng, X., Zheng, J., Lin, A., Xia, H., Zhang, Z., Gao, Q., Lv, W., & Liu, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104197 · Cited by 48
Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41
Song, J., Li, Q., Everaert, N., Liu, R., Zheng, M., Zhao, G., & Wen, J. (2020) · Journal of Animal Science · doi:10.1093/jas/skz396 · Cited by 45
“…such as lipopolysaccharide-induced tumor necrosis factor (LITAF), interferon-γ (IFN-γ), interleukin-6 (IL-6), and inducible nitric oxide synthase, which in turn modifies the intestinal barrier and immune function (Whelan, 2011; Vogt et al., 2015; Ferenczi et al., 2016; Kareem et al., 2017).”
BackgroundFernández, J., Redondo-Blanco, S., Miguélez, E. M., Villar, C. J., Clemente, A., & Lombó, F. (2015) · AIMS Microbiology · doi:10.3934/microbiol.2015.1.48 · Cited by 46
Thiam, M., Sánchez, A. L. B., Zhang, J., Zheng, M., Wen, J., Zhao, G., & Wang, Q. (2021) · Animals · doi:10.3390/ani11123498 · Cited by 40
Farzamnia, S., Shavakhi, A., Minakari, M., Peykar, M., Taghipour, G., Tayebi, A., Hashemi, H., & Shavakhi, S. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.135157 · Cited by 36
“[7-9] However, the benefits are likely to be strain-specific[10] and Bifi dobacterium infantis has resulted in significant improvement in almost all IBS symptoms.”
BackgroundHalland, M., & Talley, N. J. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.207 · Cited by 40
Wang, W., Xin, H., Fang, X., Dou, H., Liu, F., Huang, D., Han, S., Fei, G., Zhu, L., Zha, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175276 · Cited by 32
Alexea, O., Bacârea, V., & Piqué, N. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615615050 · Cited by 28
Editorial: The Importance of Systematic Reviews and Meta-Analyses of Probiotics and Prebiotics
Whelan, K. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.258 · Cited by 28
Self-citationThe effects of inulin on the mucosal morphology and immune status of specific pathogen-free chickens
Song, J., Li, Q., Li, P., Liu, R., Cui, H., Zheng, M., Everaert, N., Zhao, G., & Wen, J. (2018) · Poultry Science · doi:10.3382/ps/pey260 · Cited by 30
“…of proinflammatory cytokines, such as lipopolysaccharide-induced tumor necrosis factor (TNF) factor (LITAF), interferon-γ (IFN-γ), interleukin-6 (IL-6), and inducible nitric oxide synthase (iNOS), which modifies intestinal barrier function (Whelan, 2011; Vogt et al., 2015; Ferenczi et al., 2016).”
BackgroundRecent insight into oligosaccharide uptake and metabolism in probiotic bacteria
Abou Hachem, M., Andersen, J. M., Barrangou, R., Møller, M. S., Fredslund, F., Majumder, A., Ejby, M., Lahtinen, S. J., Jacobsen, S., Lo Leggio, L., et al. (2013) · Biocatalysis and Biotransformation · doi:10.3109/10242422.2013.828048 · Cited by 25
“…into the Lactobacillus and Bifi dobacterium genera have been shown to confer protection against pathogen infections and alleviate allergic disorders, certain gastrointestinal disorders, bowel cancer, and other conditions (Cryan & Dinan 2012; Leyer et al. 2009; Tang et al. 2010; Whelan 2011).”
BackgroundChronic constipation and treatment options (Review)
El‐Salhy, M., Svensen, R., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1770 · Cited by 24
Kim, J. Y., Park, Y. J., Lee, H. J., Park, M. Y., & Kwon, O. (2017) · Food Science and Biotechnology · doi:10.1007/s10068-017-0296-7 · Cited by 24
“However, their benefits are likely to be strain-specific [6].”
BackgroundAguilera, M., Vergara, P., & Martínez, V. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0241-0 · Cited by 28
Recent insight in α-glucan metabolism in probiotic bacteria
Møller, M. S., Goh, Y. J., Viborg, A. H., Andersen, J. M., Klaenhammer, T. R., Svensson, B., & Hachem, M. A. (2014) · Biologia · doi:10.2478/s11756-014-0367-7 · Cited by 26
Vindigni, S. M., Broussard, E. K., & Surawicz, C. M. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.832501 · Cited by 24
Adams, D., Schiffgen, M., Kundu, A., Dagenais, S., Clifford, T., Baydala, L. T., King, W. J., & Vohra, S. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000439 · Cited by 20
“The most commonly reported herb used in our study was echinacea, including by patients with IBD, which may be of potential concern because of its immunomodulating effects.”
BackgroundInfluentialThe Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?
Tavakoli, A., & Flanagan, J. (2019) · Antibiotics · doi:10.3390/antibiotics8030088 · Cited by 20
Manipulation of the Microbiota Using Probiotics
Grimm, V., & Riedel, C. U. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_8 · Cited by 20
Implementation of systematic reviews in EFSA scientific outputs workflow
O'Connor, A. M. C., Löveï, G. L., Eales, J. F., Frampton, G. K., Glanville, J., Pullin, A. S., & Sargeant, J. M. (2012) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2012.en-367 · Cited by 19
“…Braegger et al., 2011; Brenner et al., 2009; Chmielewska and Szajewska, 2010; Hempel et al., 2012; Holte et al., 2012; Hoveyda et al., 2009; Jonkers et al., 2012; Mihatsch et al., 2012; Moayyedi et al., 2010; Salari et al., 2012; Vouloumanou et al., 2009; Whelan, 2011; Whelan and Myers, 2010).”
The role of gut microbiota in the treatment of irritable bowel syndrome
Leylabadlo, H. E., Heravi, F. S., Soltani, E., Abbasi, A., Kafil, H. S., Parsaei, M., Sanaie, S., Ahmadian, Z., & Ghotaslou, R. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000284 · Cited by 19
“A review study about the effects of prebiotic interventions in IBS sufferers finalized that the reaction of such patients to prebiotic compounds are dose-dependent; in this way that the high doses (with the amount of >7 g per day) and low doses (5 g per day) of oligofructose significantly intensified and improved the…”
BackgroundGuyonnet, D., Naliboff, B. D., Rondeau, P., Mayer, E. A., & Chassany, O. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000275 · Cited by 18
Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies
Kang, Y., Pan, W. D., & Cai, Y. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-116387 · Cited by 13
Treatment of chronic diarrhoea
Li, Z., & Vaziri, H. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.11.005 · Cited by 13
Khodadoostan, M., Shavakhi, A., Sherafat, Z., & Shavakhi, A. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_216_17 · Cited by 14
“2 Advanced Biomedical Research | 2018 studies have shown that uses of probiotics were useful in IBS symptoms such as abdominal pain.[14] Nevertheless, it cannot say confidentially that uses of probiotics are universally recommended in IBS patients because of many factors, including subtypes of IBS (IBS‐D, IBS‐C, and I…”
Steiner, T. S. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.05.006 · Cited by 15
Soroko, M., & Zaborski, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234117 · Cited by 11
“Studies with humans have demonstrated the roles of probiotic supplementation in decreasing stress responses and improving mood in patients with major depressive disorder [10], irritable bowel syndrome [11] or chronic fatigue [12].”
BackgroundVedantam, S., Graff, E., Khakoo, N. S., Khakoo, N. S., & Pearlman, M. Y. (2023) · Current Gastroenterology Reports · doi:10.1007/s11894-023-00861-0 · Cited by 11
DEVELOPMENT OF PRODUCT CONTAINING MICROENCAPSULATED PROBIOTICS: AN UPDATE ON ISSUES
Alli, S. M. A. (2013) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v3i5.600 · Cited by 11
A Snapshot into the Metabolism of Isomalto-oligosaccharides in Probiotic Bacteria
Hachem, M. A., Møller, M. S., Andersen, J. M., Fredslund, F., Majumder, A., Nakai, H., Leggio, L. L., Goh, Y. J., Barrangou, R., Klaenhammer, T. R., et al. (2013) · Journal of Applied Glycoscience · doi:10.5458/jag.jag.jag-2012_022 · Cited by 10
Anwar, M., Mros, S., McConnell, M. A., & Bekhit, A. E. A. (2022) · Nutrients · doi:10.3390/nu14102128 · Cited by 12
Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time
Jayasinghe, M., Damianos, J., Prathiraja, O., Oorloff, M. D., K, G. M. N., Nadella, A., Caldera, D., & Mohtashim, A. (2023) · Cureus · doi:10.7759/cureus.43404 · Cited by 9
“Based on data obtained from four clinical trials conducted on adults, it has been observed that lower doses may be effective and high doses may have a negative impact on symptoms [43,44].”
Literature review: ‘non‐IgE‐mediated immune adverse reactions to foods’
Mills, E. N. C., Marsh, J. T., Boyle, R. J., Hoffmann‐Sommergruber, K., Dupont, D., Bartra, J., Bakalis, S., McLaughlin, J. T., & Shewry, P. R. (2013) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2013.en-527 · Cited by 7
Chobdar, N., & Ahmadizadeh, C. (2020) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.14.1.84 · Cited by 5
An Update on Probiotic Safety and Efficacy
Naon, H. (2015) · Cited by 5
Mon cerveau et mon intestin communiquent, parfois mal !
Bonaz, B. L., & Pellissier, S. (2013) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2013.10.004 · Cited by 6
Kapler, M., Kotula, J., Mąsior, M. N., Zinkow, K., & Gawlik, Ł. M. (2024) · Quality in Sport · doi:10.12775/qs.2024.18.53478 · Cited by 5
“…review concluded that while prebiotics can benefit gut health, their use in IBS should be personalized due to variable tolerance among patients [28] Diverticular Disease DD includes a spectrum of conditions related to the formation of diverticula, small bulging pouches in the lining of the…”
BackgroundModification of the gastrointestinal microbiota and its application to clinical nutrition
Whelan, K. (2012) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2012.01282.x · Cited by 3
Self-citationEffectiveness Of Probiotics In Irritable Bowel Syndrome: A Systematic Review With Meta-Analysis
Nikfar, S., Mozafari, S., Didari, T., & Abdollahi, M. R. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.799 · Cited by 3
PROSPECTIVE ACTION PLAN FOR DEVELOPING PRODUCT CONTAINING MICROENCAPSULATED PROBIOTICS
Saikh, M. A. A. (2013) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.04846 · Cited by 3
The Influence of Microbiota on Gastrointestinal Motility
Raja, S. M., Batra, V., & Srinivasan, S. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_6 · Cited by 3
Nutritional Supplementation in Ehlers-Danlos Syndrome
Castori, M., Bruschini, M., & Blundo, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00017-5 · Cited by 5
Prebiotics, Probiotics, Synbiotics, and Phage Therapy
ROSENBERG, E. B., & Zilber‐Rosenberg, I. (2013) · Springer eBooks · doi:10.1007/978-3-319-04241-1_10 · Cited by 2
Probióticos, prebióticos y simbióticos en el síndrome de intestino irritable
Calderón, E. G., Montes, P., & Monge, E. (2012) · ACTA MEDICA PERUANA · Cited by 5
Orel, R., & Reberšak, L. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00012-5 · Cited by 1
Ahmadizadeh, C., & Mirzaei, H. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.63544 · Cited by 1
Probiotics and Prebiotics in the Treatment of Irrıtable Bowel Syndrome and Functional Dyspepsia
Ağca, G., Yalçın, E., & Göktaş, Z. (2019) · Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.21020/husbfd.437227 · Cited by 1
“Bunlara ek olarak probiyotik ve prebiyotik tedavilerinin etkili olduğu bildirilmiştir (Geboes, 2001; Katz, 2002; Whelan, 2011).”
BackgroundAdeli, H., Ahmadizadeh, C., & Zali, M. H. S. (2022) · Quarterly of Horizon of Medical Sciences · doi:10.32598/hms.28.3.3277.3 · Cited by 2
Metadata
- Authors
- Whelan, K.
- Affiliations
- King's College London (GB)
- Corresponding author
- Whelan, Kevin
- ORCID
- Whelan, Kevin
- Venue
- Current Opinion in Clinical Nutrition and Metabolic Care
- Published
- 2011-11
- Volume
- 14
- Issue
- 6
- Pages
- 581-587
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W2001298761
- Cited by
- 120
- References
- 28
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 8 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 12 · 2015: 14 · 2014: 21 · 2013: 20 · 2012: 11
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, probiotics, prebiotics, gut microbiota, dysbiosis, IBS pathogenesis, strain-specific effects, abdominal pain, flatulence, gastroenteritis, immune activation
- MeSH terms
- Systematic Reviews as Topic, Dose-Response Relationship, Drug, Flatulence, Humans, Meta-Analysis as Topic, Abdominal Pain, Randomized Controlled Trials as Topic, Probiotics, Gastrointestinal Tract, Irritable Bowel Syndrome, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.